HeartSciences (HSCSW) Payables (2022 - 2026)

HeartSciences has reported Payables for 5 years, with the latest figure at $3.5 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 19.76% year-over-year to $3.5 million; the trailing twelve-month figure through Jan 2026 stood at $3.5 million (up 19.76% YoY), and the FY2025 full-year result was $2.9 million, up 202.67% from the prior year.
• Payables for Q1 2026 stood at $3.5 million, up from $817390.0 in the prior quarter.
• The five-year high for Payables was $3.5 million in Q1 2026, with the low at $396506.0 in Q3 2024.
• Historically, Payables has averaged $1.7 million across 5 years, with a median of $1.5 million in 2023.
• The largest YoY upside for Payables was 360.11% in 2025 against a maximum downside of 69.08% in 2025.
• HeartSciences' Payables stood at $1.9 million in 2022, then jumped by 30.13% to $2.5 million in 2023, then grew by 5.52% to $2.6 million in 2024, then tumbled by 69.08% to $817390.0 in 2025, then soared by 329.47% to $3.5 million in 2026.
• The last three Payables figures came in at $3.5 million (Q1 2026), $817390.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.